Source: International Congress 2014 – Pathways to personalised medicine in obstructive lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Castaldi (Boston, United States of America). COPD prediction by using imaging and genetic profiles. International Congress 2014 – Pathways to personalised medicine in obstructive lung disease

Member's Comments

No comment yet.

Related content which might interest you: MRI equilibrium signal mapping is a quantitative and reproducible alternative to CT for the estimation of lung density in COPD Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation Year: 2012 COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging Source: Eur Respir J, 52 (5) 1801570; 10.1183/13993003.01570-2018 Year: 2018 A simple algorithm for the identification of clinical COPD phenotypes Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017 Year: 2017 Comparison of multidimensional assessment systems with regard to risk prediction for exacerbations of COPD Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Simultaneous analysis of clinical markers for predicting increased lung function fluctability in stable asthma Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes Source: ERS Lung Science Conference 2016 Year: 2016 Comparing the discriminative properties of different staging systems with regard to functional characterization of patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005 Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Comparison of different staging methods for COPD in predicting outcomes Source: Eur Respir J, 51 (3) 1700577; 10.1183/13993003.00577-2017 Year: 2018 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 A predictive model for classifying COPD patients according to CT emphysema extent by using functional data and BMI Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Multi-scale analysis of imaging features to study exacerbation susceptible COPD Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017